Impact of low-dose quetiapine-use on glycosylated hemoglobin, triglyceride and cholesterol levels.

Højlund, Mikkel; Støvring, Henrik; Andersen, Kjeld; Correll, Christoph U; Hallas, Jesper

Højlund, Mikkel; Støvring, Henrik; Andersen, Kjeld; Correll, Christoph U; Hallas, Jesper.

Affiliation

Højlund M; Department of Public Health, Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.
Støvring H; Mental Health Services Region of Southern Denmark, Department of Psychiatry Aabenraa, Aabenraa, Denmark.
Andersen K; Department of Public Health, Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.
Correll CU; Department of Public Health, Aarhus University, Aarhus, Denmark.
Hallas J; Department of Clinical Medicine, Psychiatry, University of Southern Denmark, Odense, Denmark.

Acta Psychiatr Scand ; 147(1): 105-116, 2023 01.

Article in En | MEDLINE | ID: mdl-36281759

Subject(s)

Glycated Hemoglobin; Female; Humans; Middle Aged; Cholesterol, HDL; Cholesterol, LDL; Quetiapine Fumarate/adverse effects; Triglycerides; Male

Key words

Antipsychotics; dyslipidemia; hyperglycemia; off-label; quetiapine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Glycated Hemoglobin Limits: Female / Humans / Male / Middle aged Language: En Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Glycated Hemoglobin Limits: Female / Humans / Male / Middle aged Language: En Year: 2023 Type: Article